AKRX up +5.08% percent Today $AKRX High is at 37.51 and the

New Post Public Reply Private Reply Replies (0) Message Board
Lucky Jimmy
AKRX up +5.08% percent Today $AKRX High is at 37.51 and the Low 35.10 with current volume of 699,903.

Recent News posted below.

Akorn Inc AKRX other info.
http://investorshangout.com/Akorn-AKRX-53272/

AKRX Akorn Inc Recent Headline News

Zacks Rank #1 Additions for Thursday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - 1 hr 53 mins ago
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Thursday
ICUI: 84.22 (-0.51), AKRX: 37.50 (+2.07), WPC: 66.86 (+0.46), FLWS: 9.08 (+0.05), MMSI: 15.25 (-0.15)

Stocks Open With Mild Losses; American Eagle, Macys Jump
at Investor's Business Daily - Wed Nov 12, 9:35AM CST
Stocks opened to mild losses in mixed trade Wednesday, as company earnings reports fueled much of the early action. The Dow Jones industrial average and the S&P 500 each dipped 0.2%. The Nasdaq shed a bit less than 0.1%. The stock market today got...
AMBA: 48.53 (-0.86), AKRX: 37.50 (+2.07), AEO: 13.62 (-0.18), M: 60.73 (-0.84), FANG: 64.00 (-0.81)

Look for Shares of Akorn to Potentially Rebound after Yesterday's 1.18% Sell Off
Comtex SmarTrend(R) - Mon Nov 10, 5:02PM CST
Akorn (NASDAQ:AKRX) traded in a range yesterday that spanned from a low of $35.02 to a high of $36.36. Yesterday, the shares fell 1.2%, which took the trading range below the 3-day low of $35.04 on volume of 2.6 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
AKRX: 37.50 (+2.07)

Akorn (AKRX) Downgraded From Buy to Hold
at The Street - Mon Nov 10, 8:19AM CST
Akorn (AKRX) has been downgraded by TheStreet Ratings from Buy to Hold with a ratings score of C+.
AKRX: 37.50 (+2.07)

Health Sell-Offs Drag On IBD 50
at Investor's Business Daily - Fri Nov 07, 6:31PM CST
The IBD 50 was lower last week as several stocks in health care sold off, dragging down the index's performance. After two weeks of feverish gains, the IBD 50 components cooled off the first week of November. The index was down 1.4% last week,...
BCC: 37.12 (-0.08), LCI: 49.80 (+0.07), AKRX: 37.50 (+2.07), AFSI: 53.27 (+1.53), EXPE: 86.88 (-0.23), FFIV: 125.47 (-0.29), SLXP: 96.48 (+0.93), MPWR: 45.21 (-0.17), TMH: 55.02 (+1.24), ATHM: 43.07 (+0.07)

Stocks In Retreat After Jobs Report; Monster Beverage Gains
at Investor's Business Daily - Fri Nov 07, 9:31AM CST
jobs report, Arista Networks earnings, leading stocks, Monster Beverage stock, breakout stocks Stocks opened lower Friday after disappointing gains in October payrolls. The Nasdaq slumped 0.4% due to weakness in networking, biotech and solar issues....
MNST: 108.70 (+0.79), ANET: 77.98 (+0.74), AKRX: 37.50 (+2.07), ATHM: 43.07 (+0.07)

A/D Rating Helps Spot What The Pros Are Buying
at Investor's Business Daily - Thu Nov 06, 5:41PM CST
If you're prepping a small patch of land, a shovel and a hoe from Home Depot (HD) will suffice. But if you have acres to dig up, then you'll need industrial-size earth-moving equipment. In the stock market, it takes big money from professional...
BCC: 37.12 (-0.08), HD: 98.95 (+0.46), AKRX: 37.50 (+2.07), ILMN: 188.66 (+1.74)

SmarTrend Watching for Potential Rebound in Shares of Akorn After 9.12% Loss
Comtex SmarTrend(R) - Thu Nov 06, 4:05PM CST
Akorn (NASDAQ:AKRX) traded in a range yesterday that spanned from a low of $36.35 to a high of $42.49. Yesterday, the shares fell 9.1%, which took the trading range below the 3-day low of $41.17 on volume of 6.9 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
AKRX: 37.50 (+2.07)

Stocks Gain On Draghi Comments, Economic Data
at Investor's Business Daily - Thu Nov 06, 3:25PM CST
Stocks scored modest gains Thursday, thanks in part to ECB President Mario Draghi's pledge for stimulus and better-than-expected domestic data on jobless claims and productivity. The Dow Jones industrial average and the S&P 500 rose 0.4% each. Both...
GPRO: 78.48 (+1.63), SWIR: 38.72 (+1.42), AAP: 146.24 (-0.03), AKRX: 37.50 (+2.07), BABA: 116.32 (-1.88)

Akorn's (AKRX) CEO Rajat Rai on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Nov 06, 3:17PM CST

AKRX: 37.50 (+2.07)

Akorn (AKRX) Stock Lower Today After Reporting Third Quarter Earnings Results
at The Street - Thu Nov 06, 2:50PM CST
Shares of Akorn (AKRX) are down after reporting 2014 third quarter earnings that revealed $39.9 million in costs related to price increases.
AKRX: 37.50 (+2.07)

Stocks Up Slightly After Choppy Action
at Investor's Business Daily - Thu Nov 06, 12:26PM CST
Stocks were modestly higher after struggling for direction earlier. Overall, equities have wavered Thursday amid news of potential stimulus by the European Central Bank and better-than-expected data on jobless claims and productivity. The Dow Jones...
GPRO: 78.48 (+1.63), SWIR: 38.72 (+1.42), AKRX: 37.50 (+2.07), FRGI: 56.34 (-0.33), BABA: 116.31 (-1.89)

Akorn drops after earnings report
Seeking Alpha - at Seeking Alpha - Thu Nov 06, 12:20PM CST

AKRX: 37.50 (+2.07)

Video: Akorn Reports 'Messy' Quarter, Slamming Stock
at Investor's Business Daily - Thu Nov 06, 12:19PM CST
Generic-drug maker and IBD 50 stock Akorn (AKRX) on Thursday reported Q3 results complicated by accounting issues, sending the stock down nearly 11% in afternoon trade on the stock market today . The company's revenue totaled $132.7 million, up 62%...
AKRX: 37.50 (+2.07)

Stocks Down As Early Gains Fade; Generac Dives, Tableau Soars
at Investor's Business Daily - Thu Nov 06, 9:41AM CST
Stocks twisted opening gains into thin losses Thursday, as economic news and company reports fed the bulk of early action. The S&P 500 dipped 0.2%. The Nasdaq hovered a fraction into the red and the Dow Jones industrial average held effectively flat....
WFM: 46.58 (-0.90), TSLA: 252.25 (+3.15), AAP: 146.24 (-0.03), AKRX: 37.50 (+2.07), SLXP: 96.48 (+0.93), DIS: 90.50 (+0.60), GNW: 9.27 (+0.47), CDW: 32.53 (+0.06), NVDA: 19.45 (-0.20), QCOM: 70.62 (+0.33), GNRC: 41.88 (+0.13), LOCO: 34.96 (-0.53), DATA: 82.45 (-1.00)

Akorn (AKRX) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Thu Nov 06, 8:55AM CST

AKRX: 37.50 (+2.07)

Akorn reports 3Q loss
Automated Insights - Thu Nov 06, 6:51AM CST
LAKE FOREST, Ill. (AP) _ Akorn Inc. (AKRX) on Thursday reported a loss of $11.7 million in its third quarter.
AKRX: 37.50 (+2.07)

Akorn beats by $0.02, beats on revenue
Seeking Alpha - at Seeking Alpha - Thu Nov 06, 6:49AM CST

AKRX: 37.50 (+2.07)

Akorn Reports Preliminary 2014 Third Quarter Results
GlobeNewswire - Thu Nov 06, 6:30AM CST
Akorn, Inc. (Nasdaq:AKRX), a niche pharmaceutical company, today reported preliminary financial results for the fiscal third quarter ended September 30, 2014.
AKRX: 37.50 (+2.07)

Akorn Inc. (AKRXQ) Stock Research Links

AKRXQ Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

RELISH 2026: Orange County's Ultimate Food & Drink Bash

Updated Category News Views 1

A Festival Like No Other If there’s anything Orange County knows how to do, it’s throw a party. And here comes RELISH, a three-day feast for the senses that’ll have foodies talking for weeks. Organized by Celebrity Chef Jamie Gwen and Event Planner Nicole Hirsty, this is not your average town fair. This is indulgence on a silver platter, set to take place from...

Continue Reading
VIN Foundation's Generous Push for Vet Education in 2027

Updated Category News Views 3

Scholarships Fueling Future Veterinarians Not a day goes by without someone singing the praises of VIN Foundation's efforts. This time, they're spotlighting two fresh souls embarking on their vet school journey. Mark it, folks, the 2027 Mike Dunn, DVM Veterinary Student Scholarship, birthed by Becky Godchaux, is here to soften the financial blow. Up to $140,000 per head...

Continue Reading
Enovis' Acquisition of eCential Robotics: A Game-Changer

Updated Category News Views 4

Is Enovis Making a Smart Move with eCential Robotics? Alright, folks. Here's the lowdown from a seasoned old-timer in this wild market playground. Enovis Corporation, the NYSE:ENOV ticker you've been seeing, decided to put on its big boy pants and go after eCential Robotics. This French-born player is all about surgical robotics and enabling tech—just the sort of...

Continue Reading
Phoenix Initiative Delivers Meals, Health Aid Downtown

Updated Category News Views 5

Phoenix's Fight Against Homelessness Gets Personal When you hit the streets of downtown Phoenix on a scorching Saturday morning, you're not just encountering sweltering heat; you're witnessing compassion in motion. An unexpected coalition has emerged, unraveling the web of homelessness in the heart of Arizona. Forget the stock tips, this one’s about community fortitude....

Continue Reading
Manulife's $750M US Offering: Risky or Strategic?

Updated Category News Views 2

Manulife: Debuting $750M in Subordinated Notes When it comes to Manulife's latest move, it's all about the numbers. They've priced a U.S. public offering of a meaty $750 million in subordinated notes at an enticing 6.146% interest rate. That's no pocket change, folks, and it highlights a strategy or a gamble, depending on your view. But here's the kicker: these notes may...

Continue Reading
ZERO Fresh Start: RAVEN2's New Era Begins Sept 15

Updated Category News Views 2

What's the Big Deal with ZERO? Alright, so here we go, folks—Netmarble's strapping in with their latest server for RAVEN2, and it's called ZERO. Ever heard of fresh starts? ZERO is exactly that. This isn't your usual server shuffle. Lads and ladies who've felt the grind’ll tell you, ZERO's introducing a slew of changes you might want to sit up for. Pre-registration's...

Continue Reading
Youlife Partners for Vocational Training in Ji'an

Updated Category News Views 4

Big Moves in Education for Youlife Youlife Group Inc., the bigwig in China's blue-collar work scene, just inked a strategic pact that's worth a second look—or several. Teaming up with Ji'an Industry-Education Integration Technology Co., Ltd., they've got a plan to turn heads and maybe some profit margins too. This isn't just about signing papers; it's about forging a...

Continue Reading
Zepp Health's Q2 2026 Results: Growth Amid Struggles

Updated Category News Views 1

Revenue Growth, Yet the Road Is Rocky Buckle up, investors, because Zepp Health Corporation's (NYSE: ZEPP) latest financials are a bit of a mixed salad—there's some good and some bad tossed in. Reporting a revenue of $63.5 million for the second quarter of 2026, the company managed to eke out a 6.9% increase year-over-year. But before you pop the champagne, let's dig a...

Continue Reading
AB 2529: New Bill Awaits Governor's Decision

Updated Category News Views 1

Legislative Milestone or Just Another Step? Hidden Hills, California is causing a bit of a ripple in the state's legislative waters with Assembly Bill 2529. Now that the bill has sailed through the California Legislature with impressive bipartisan support—it passed the State Senate 39-0 and the Assembly 62-4—it's sitting pretty on the Governor's desk. The question...

Continue Reading
Subtle Cosmetic Dentistry Transformations Boost Confidence

Updated Category News Views 2

Rethinking Cosmetic Dentistry: Small Changes, Big Impact Listen up, folks. Turns out, it's the little tweaks that make your grin shine, not an expensive overhaul. This little nugget comes straight from the mouth of Dr. Jared Giatras at Giatras Family Dentistry, Murfreesboro. The old-school perception that you need to wipe the slate clean and start fresh with a chiclet...

Continue Reading

Top 5 Most Recently Viewed Articles

Adial Pharmaceuticals Advances AD04 Following FDA Meeting

Updated Category News Views 217

Positive Developments for Adial Pharmaceuticals and AD04 Adial Pharmaceuticals, Inc. (NASDAQ: ADIL), a biopharmaceutical company dedicated to addressing addiction and related disorders, recently received significant updates from its End of Phase 2 (EOP2) meeting with the U.S. Food and Drug Administration (FDA). This meeting, which was held to discuss the development of...

Continue Reading
Tradr Unveils Innovative 2X Leveraged ETFs for Quantum Stocks

Updated Category News Views 153

Exciting New ETFs from Tradr ETFs Tradr ETFs has just launched innovative financial products that cater specifically to traders keen on quantum computing technology. Among the new offerings are the Tradr 2X Long QUBT Daily ETF and the Tradr 2X Long RGTI Daily ETF. These funds are designed to provide traders with 200% daily exposure to Quantum Computing Inc. (NASDAQ: QUBT)...

Continue Reading
36Kr Holdings Inc. Launches European Central Station Initiative

Updated Category News Views 185

36Kr Holdings Inc. (NASDAQ: KRKR) made waves back in 2024 by launching the 36Kr European Central Station, a bold move aimed at expanding its foothold in the global market. The chatter around this initiative was palpable as traders eyed how this could reshape connections between Chinese startups and international players. You had to wonder—would it just be another flash...

Continue Reading
Apple's Leadership Changes and Upcoming Innovations Unveiled

Updated Category News Views 228

Apple's Recent Executive Changes Impacting the Tech Giant This past week brought forth noteworthy changes and developments at Apple Inc. (NASDAQ: AAPL), illustrating the company’s adaptability in a fast-evolving technology landscape. From potential executive exits to a shift in operational strategies, Apple is poised for significant transformations that aim to...

Continue Reading
Experian Dividend Exchange Rate Announcement and Key Details

Updated Category News Views 157

Experian Announces Dividend Exchange Rate Experian (OTC: EXPGF), a prominent global information services provider, has recently announced the exchange rate for its forthcoming first interim dividend. This dividend payment, which is set at 19.25 US cents per share, presents an excellent opportunity for investors. It is crucial for shareholders to take note of the details...

Continue Reading